ORCL CEO Michael Sicilia acquires 1,037,412 options at $308.46

Michael D. Sicilia, listed as Chief Executive Officer, reported the acquisition of a large stock option award in Oracle Corporation (ORCL).

Rhea-AI Filing Summary

Michael D. Sicilia, listed as Chief Executive Officer, reported the acquisition of a large stock option award in Oracle Corporation (ORCL). The Form 4 shows a derivative transaction dated 09/24/2025 in which 1,037,412 stock options were acquired with an exercise (conversion) price of $308.46. The filing reports the options as directly beneficially owned following the transaction.

The options have an exercisable/expiration date entry of 09/24/2035 and the form states that 25% of the shares subject to the option vest annually on each anniversary of the grant date. The form is signed by an attorney-in-fact, Aimee Weast, under power of attorney dated 06/12/2025, with signature dated 09/26/2025.

Positive

• Large, disclosed award: The filing explicitly reports acquisition of 1,037,412 stock options, providing transparency on executive compensation.
• Clear vesting schedule: The Form 4 states 25% vests annually, giving investors explicit timing of when options become exercisable.

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: CEO received a sizable long-dated option grant of 1,037,412 options at $308.46 with standard annual vesting.

The Form 4 documents a single reporting-person filing by Michael D. Sicilia showing acquisition (code A) of 1,037,412 stock options on 09/24/2025 at a stated conversion price of $308.46. The disclosure that 25% vests each anniversary indicates a four-year vesting schedule beginning at grant. The options are recorded as directly beneficially owned and have an exercisable/expiration date noted as 09/24/2035, implying a long option term as disclosed. The filing was executed via power of attorney, which is properly noted on the form.

Compensation Analyst

TL;DR: A large option award was granted to the CEO with multi-year vesting and a $308.46 strike, consistent with executive compensation disclosures.

The reported derivative transaction shows acquisition of 1,037,412 options with a conversion price of $308.46 and annual 25% vesting, which is a common structure for executive equity incentives. The option details (amount, price, vesting cadence, and long dated exercisability entry) are explicitly stated on the Form 4 and permit stakeholders to model potential future dilution and cost when combined with company disclosures elsewhere.

Insider Trade Summary

Grant/Award: 1,037,412 shares

Grant/Award 1 txn

Insider Sicilia Michael D.

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	1,037,412	$0.00	$0.00

Holdings After Transaction: Stock Option — 1,037,412 contracts (Direct)

Footnotes (1)

1. F1. 25% of the shares subject to the option vest annually on each anniversary of the grant date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transaction did Michael D. Sicilia report for ORCL?

The Form 4 reports acquisition of 1,037,412 stock options on 09/24/2025 with a conversion price of $308.46.

What is the vesting schedule for the options reported on ORCL Form 4?

The filing states that 25% of the shares subject to the option vest annually on each anniversary of the grant date.

Are the reported options directly or indirectly owned?

The Form 4 lists the options as direct (D), with 1,037,412 options beneficially owned following the transaction.

When is the option exercisable or expiring according to the filing?

The Form 4 shows an exercisable/expiration date entry of 09/24/2035 for the reported derivative security.

Who signed the Form 4 for Michael D. Sicilia?

The form is signed by Aimee Weast as attorney-in-fact under a power of attorney dated 06/12/2025, with signature dated 09/26/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/26/2025 - 08:27 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Sicilia Michael D.

(Last) (First) (Middle)

C/O DELPHI ASSET MGMT CORPORATION

200S.VIRGINIA ST., SUITE 625

(Street)

RENO NV 89501

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ORACLE CORP [ ORCL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$308.46	09/24/2025		A		1,037,412		(1)	09/24/2035	Common Stock	1,037,412	$0	1,037,412	D

Explanation of Responses:

1. 25% of the shares subject to the option vest annually on each anniversary of the grant date.

	/s/ Aimee Weast by Aimee Weast, Attorney in Fact for Michael D. Sicilia (POA filed 6/12/2025)	09/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.